PRP Injection (Platelet-Rich Plasma): Benefits, Evidence and Recovery

SMS
Email
Facebook
LinkedIn
Share
WhatsApp

Written by Amit Sharma, MD
Interventional Spine and Pain Management Physician, SpinePain Solutions. This guide explains how PRP fits into diagnosis-specific care, including its evidence, limitations and alternatives.

Platelet-rich plasma (PRP) injection uses a concentrated preparation of platelets from your own blood. It may be considered for selected joint or tendon conditions, usually alongside rehabilitation and activity modification. It is not a single standardized treatment, and results from one body area cannot be assumed to apply to another.

The practical question is not simply whether PRP is “regenerative.” It is whether an injection has a reasonable chance of improving your particular pain and function, compared with other options, at an acceptable cost and risk.

Quick Answer

PRP may help some patients, but it should not be recommended for every painful joint or tendon. Knee osteoarthritis is better studied than many other uses, yet findings remain inconsistent. Tendon evidence varies substantially. If benefit occurs, it is usually assessed over weeks, not minutes. Temporary soreness can occur without proving healing. There is no universal number of injections, and repeating treatment should have a clear clinical rationale.

Table of Contents

What Is Platelet-Rich Plasma (PRP) Injection?

Plasma is the liquid portion of blood. Platelets are small blood-cell fragments involved in clotting and biological signaling. To prepare PRP, a blood sample is processed in a centrifuge and a platelet-enriched portion is collected for injection.

Platelets release growth factors and other signaling proteins that can affect inflammation and tissue-repair pathways. These mechanisms explain why PRP is being studied. They do not establish that every injection rebuilds tissue, reverses arthritis or produces better results than standard treatment.

PRP used on this page refers to an autologous blood preparation, not a corticosteroid injection and not a donor-derived tissue product. A general explanation is available from AAOS OrthoInfo.

PRP Injection at a Glance

Blood source	Your own blood, processed for the planned injection.
Visit length	Includes evaluation, blood collection, preparation and injection; complex or multiple targets take longer.
Comfort measures	Local numbing and, when appropriate, sedation depend on the target and patient. Sedation requires additional instructions and a driver.
Discharge versus recovery	Usually outpatient. Going home the same day does not mean immediate return to sports or unrestricted loading.
Expected response	If helpful, change is generally assessed over weeks to months. Some patients do not benefit.
Treatment number	Diagnosis-specific; one injection or a planned series may be discussed.
Cost and coverage	Many musculoskeletal uses are self-pay. Verify the applicable policy and request the total proposed cost.

Does PRP Actually Work? Read the Evidence by Condition

PRP is neither a proven treatment for every injury nor a treatment that never helps anyone. Its value must be judged for the specific condition, preparation, comparison treatment and outcome being measured.

For knee osteoarthritis, the 2021 AAOS guideline allows that PRP may improve pain and function, but rates the recommendation as limited because findings are inconsistent. In contrast, the 2021 RESTORE trial, involving 288 participants, found no significant advantage of three weekly PRP injections over saline for its primary pain and cartilage-volume outcomes at 12 months.

These findings should be discussed together. A favorable study does not guarantee your outcome, and a negative study should not be dismissed simply because a clinic uses a different preparation. Product differences are a reason for better research, not automatic proof of superiority.

Which Tendon and Joint Conditions May Respond to PRP?

The table below is a discussion guide, not a list of conditions for which PRP is automatically recommended. Persistent symptoms alone do not establish candidacy.

Condition	What patients should know	Treatment context
Knee osteoarthritis	Among the better-studied uses. Some trials report symptom benefit, but the AAOS recommendation is limited and RESTORE was negative for its primary outcomes. Cartilage restoration is not established.	Discuss alongside exercise, weight management when relevant, bracing and other appropriate treatments. Knee PRP guide.
Tennis elbow	Some comparisons favor PRP over steroid later in follow-up, but that is not the same as showing benefit over placebo. A 2021 Cochrane review found little or no clinically important placebo-controlled benefit.	Loading rehabilitation and activity modification remain important. An injection should follow an evidence-aware discussion, not a promise of tendon repair.
Rotator-cuff tendinopathy or partial tears	Evidence is mixed. The 2025 AAOS guideline does not support routine PRP use for these conditions.	Assess tear severity, weakness, functional loss and rehabilitation response. Shoulder PRP guide.
Chronic midportion Achilles tendinopathy	A 2021 randomized trial found no benefit of a single intratendinous PRP injection over sham for tendon dysfunction at six months. This should not be listed as a reliably responsive indication.	Prioritize an appropriate rehabilitation plan. Midportion disease, insertional disease and rupture are different diagnoses.
Patellar tendinopathy	In a 2019 randomized trial, a single leukocyte-rich or leukocyte-poor PRP injection plus rehabilitation was not superior to saline plus rehabilitation.	Progressive tendon loading is central. More injections should not be assumed to overcome a negative response.
Plantar fasciitis and other persistent tendon complaints	PRP is sometimes considered, but the evidence and competing treatments must be reviewed for the exact diagnosis. Knee or elbow findings cannot establish benefit here.	Clarify the target and whether loading, footwear changes, other nonsurgical treatment or specialist assessment is more appropriate.
Hip, shoulder-joint or thumb arthritis	The evidence base is less established than for knee osteoarthritis. These are separate indications, not interchangeable “arthritis PRP” treatments.	Review diagnosis-specific evidence, joint damage and standard alternatives before choosing a self-pay injection.
Ligament sprains or muscle injuries	A general claim that PRP accelerates every sports injury is not justified. A complete rupture or mechanically unstable injury needs a different assessment.	Many injuries improve with rehabilitation. PRP does not replace indicated stabilization or repair.
SI-joint or discogenic back pain	Evidence is still evolving, and different spinal targets have different risks. PRP should not be described as a general solution for back pain or nerve compression.	See SI-joint PRP and intradiscal PRP for target-specific discussions.

Why a Positive Trial Does Not Make PRP Routine Care

A 2021 rotator-cuff trial found better short-term pain and function after PRP than after corticosteroid at three months, but no sustained advantage at 12 months. The broader 2025 AAOS assessment still does not support routine PRP for cuff tendinopathy or partial tears. Selected use, routine use and PRP added during surgical repair are different questions.

Who Might Be a Reasonable Candidate?

A reasonable discussion begins with a diagnosis, not a sales package. Features that may support consideration include:

A clearly identified joint or soft-tissue target that fits the symptoms and examination.
Persistent functional limitation despite an appropriate trial of lower-risk care.
Evidence for the proposed use that the patient understands, including negative findings.
No urgent structural or neurological problem that requires another treatment.
A feasible rehabilitation plan and realistic goals.
An acceptable balance of procedural risk, uncertainty, cost and alternatives.

Neither age alone nor an abnormal MRI automatically determines candidacy. Diabetes, smoking, other medical conditions, platelet abnormalities and medication use may affect procedural planning. They should be reviewed individually rather than treated as explanations for every unsuccessful result.

When Another Approach May Be Better

Active infection, a suspected infected joint or an unhealed skin problem at the injection site.
A significant bleeding disorder, severe platelet abnormality or other condition requiring medical assessment before a blood-derived treatment.
A complete tendon or ligament rupture, substantial instability or a tear that needs timely specialist evaluation.
Advanced joint damage with major functional loss, where other treatment may offer more predictable benefit.
Progressive weakness, spinal cord or nerve-root compression, fracture, or another diagnosis that PRP does not correct.
An unclear pain source or expectation that one injection will reliably regenerate tissue.

A full-thickness rotator-cuff tear does not mean every patient must have surgery, but PRP is not an established replacement for a tear-specific rehabilitation or surgical plan.

Does PRP Regrow Cartilage or Prevent Surgery?

Pain relief is not proof of cartilage regrowth or tendon repair. Patients can feel better without a measurable structural change. PRP should not be advertised as reliably restoring lost cartilage, reversing arthritis or reattaching a completely torn tendon.

The RESTORE trial found no significant difference in its cartilage-volume outcome at 12 months. That result does not answer every possible PRP question, but it directly challenges a blanket cartilage-restoration claim.

If symptoms improve, a patient may choose to defer an elective operation. That is different from proving PRP prevents future surgery or slows disease progression. It should not delay evaluation when weakness, rupture, instability or severe disability calls for another approach. Read more in Does PRP Regrow Cartilage?

Not All PRP Preparations Are the Same

The useful description of PRP goes beyond a brand or the number of centrifuge spins. Important characteristics include platelet concentration and total platelet dose, injected volume, white-cell content, red-cell contamination, processing and handling, and any added substances.

PRP is not a stem-cell transplant. Bone marrow aspirate concentrate (BMAC), donor-derived tissue products and exosome products are different preparations with different evidence and regulatory questions. They should not be presented as interchangeable versions of PRP. The FDA’s patient information on regenerative products is relevant when considering products marketed as stem cells or exosomes; it should not be misread as a statement that every autologous PRP use has the same regulatory status.

Leukocyte-Poor Versus Leukocyte-Rich PRP

Leukocyte-poor (LP) PRP contains fewer white blood cells, while leukocyte-rich (LR) PRP contains more. Their biological effects can differ. However, neither label establishes that a preparation will work for every joint or tendon, and comparative evidence is not consistent across indications.

At SpinePain Solutions, LP and LR preparations are considered according to the target and treatment plan. The rationale should be explained without promising that a particular cell composition guarantees success.

Single-Spin Versus Double-Spin PRP

Single-spin and double-spin systems process blood differently. Either can produce a platelet-enriched preparation, and actual composition depends on the system and protocol. A second spin does not, by itself, establish better patient outcomes.

Our Preparation Approach

Our practice uses a double-spin preparation approach for musculoskeletal and selected spine procedures. This is a description of our technique, not proof that it outperforms every single-spin system. Patient selection, the final preparation and the evidence for the intended target remain important. See our double-spin PRP guide.

“Higher concentration,” “more growth factors” and “premium PRP” are not adequate substitutes for clinical outcome evidence. Patients should also ask whether a device’s FDA clearance concerns preparation of a blood product rather than proof of benefit for their particular diagnosis.

What Happens During a PRP Injection?

Confirm the target: Review symptoms, examination findings and relevant imaging. Agree on goals and alternatives.
Review safety and consent: Discuss medications, infection risk, medical conditions, expected discomfort, costs and uncertainty.
Collect blood: Draw the amount needed for the planned preparation.
Prepare PRP: Process the sample using the selected protocol and maintain sterile handling.
Inject the intended target: Use ultrasound, fluoroscopy or another appropriate guidance strategy depending on the anatomy and procedure.
Provide aftercare: Supply activity, medication and rehabilitation instructions, warning signs and a follow-up plan.

Local numbing may be used for comfort; the approach depends on the target and protocol. Immediate relief from an anesthetic is not evidence of a lasting PRP response. If sedation is used, follow the separate fasting, transportation and post-sedation instructions.

Image guidance helps placement, but accurate placement cannot guarantee that an otherwise ineffective treatment will become effective. Deep spinal injections are not equivalent to a superficial tendon injection in complexity or risk.

How Many PRP Injections Are Usually Needed?

There is no universal one-shot or three-shot rule

The diagnosis and evidence should determine whether to start with one injection, use a planned series, or choose no PRP at all. A package of three injections should not be described as necessary for every patient, and one injection should not be advertised as a guaranteed permanent solution.

Situation	Possible plan	Key limitation
Knee osteoarthritis	Studies have used a single injection or a series, commonly two or three. Discuss the rationale for the chosen protocol.	Injection-number findings are mixed. More injections do not guarantee more benefit; RESTORE used three without showing a significant advantage for its primary outcomes.
Selected tendon treatment	An initial injection and reassessment may be discussed, or a diagnosis-specific protocol may use a series.	A series cannot be assumed to repair a tear or overcome uncertain evidence for the indication.
SI-joint or intradiscal treatment	Require a target-specific discussion, including whether PRP is justified at all.	Do not transfer a knee injection schedule to a spinal target or recommend automatic repeat deep injections.
Recurrence after useful prior benefit	Reassess the diagnosis, duration of benefit, current function and alternatives before considering another treatment.	No blanket annual maintenance schedule is established for every condition.

The AAOS knee guideline describes inconsistent findings across injection numbers. Scheduling and spacing should therefore be explained as a chosen clinical protocol, not a universally proven requirement.

When Might Another Injection Be Reasonable?

A repeat discussion may be reasonable after meaningful partial improvement or recurrence following a useful response. Before proceeding, ask what additional benefit is expected, whether supporting evidence applies to this diagnosis, and how the extra procedure changes total cost and risk.

When there has been no meaningful improvement after the agreed assessment interval, the first step is reassessment, not automatically another syringe. Review the target, competing diagnoses, rehabilitation and whether continued PRP is justified.

Set an Assessment Plan Before the First Injection

Record baseline pain using a consistent scale.
Choose two or three relevant activities, such as stairs, walking, grip or overhead reaching.
Agree on a condition-appropriate follow-up interval and what would count as worthwhile improvement.
Record medication changes, rehabilitation and changes in activity that may influence symptoms.
Agree on what happens if benefit is partial, absent or short-lived.

How Long Does PRP Take to Work, and Can Pain Initially Get Worse?

If PRP helps, improvement is generally assessed over several weeks and sometimes longer. There is no fixed “maximum benefit at three months” rule that applies to every joint, tendon or spine procedure. Some patients do not improve despite appropriate treatment.

A useful general distinction is recovery from the injection versus improvement in the original condition. Early soreness may settle before function improves. Conversely, feeling better does not establish that a tendon has regained full load tolerance.

Johns Hopkins patient guidance describes a delayed rather than immediate response. Our dedicated PRP recovery timeline covers aftercare in more detail; the treating team’s instructions take priority.

A Pain Flare Is Not Proof of Healing

Temporary soreness, stiffness, swelling or increased pain can occur after injection. Needle trauma, the target tissue and the injected preparation can contribute. A flare does not prove that PRP is working, and a comfortable injection does not mean it failed.

Do not accept severe or escalating pain as something you must endure for regeneration. Persistent symptoms should be reviewed rather than repeatedly attributed to “the healing response.”

Activity and Rehabilitation

Aftercare depends on the treated structure, underlying injury and any additional procedure, such as tendon needling. A joint injection, tendon procedure and intradiscal injection should not share one generic return-to-sport timetable.

Follow the prescribed progression from protected activity to movement, strengthening and appropriate loading. Avoid both pushing through escalating pain and unnecessary prolonged rest. Braces, boots or assistive devices are used only when the clinical plan calls for them.

NSAIDs, Aspirin and Blood Thinners

Some clinicians limit certain NSAIDs around PRP because of concerns about platelet function or the intended biological response. However, clinical evidence does not establish one universally optimal hold interval for all drugs, preparations and indications.

Never independently stop prescribed aspirin, anticoagulants or essential medication. Any change may require coordination with the prescribing clinician. The team should also provide a safe pain-management plan and specific advice about ice, wound care and activity rather than relying on a general internet protocol.

Warning Signs: Do Not Assume These Are a Normal Flare

Contact the treating team promptly for fever, spreading redness or warmth, drainage, rapidly increasing swelling, severe or progressively worsening pain, or a new inability to use or bear weight on the treated area.

New major weakness, loss of bowel or bladder control, rapidly progressive neurological symptoms, chest pain or shortness of breath require urgent medical evaluation. After a spinal injection, severe worsening back pain with fever or neurological change needs prompt assessment.

PRP Versus Other Treatments: Compare the Goal, Not a Star Rating

There is no validated five-star “healing potential” scale that ranks PRP, steroid, exercise and surgery across unrelated conditions. Compare the actual diagnosis, evidence, expected benefit, risks and costs instead.

Option	Role	Important limitation
Rehabilitation and activity modification	Improve strength, loading tolerance and function; often the foundation of care.	Requires a diagnosis-specific plan and participation. An injection does not replace it.
PRP	A possible adjunct for selected conditions after discussing the evidence.	Delayed or absent benefit, variable preparations and often self-pay. Structural regeneration is not guaranteed.
Corticosteroid injection	May reduce symptoms in appropriate inflammatory or joint conditions.	Target, repetition, metabolic effects and proximity to planned surgery matter. Not a blanket treatment for tendon tears.
Hyaluronic acid	Sometimes offered for knee osteoarthritis after reviewing alternatives.	Guideline recommendations differ, and AAOS does not recommend routine use for knee osteoarthritis.
Tendon procedures such as TenJet	A different procedural approach for selected persistent tendon pathology.	Not interchangeable with PRP and not automatically the next step after PRP. Suitability, evidence and rehabilitation require review.
Surgery	May repair a structural injury, address instability or replace a severely damaged joint.	More involved recovery and procedure-specific risks; neither permanent pain relief nor a successful repair is guaranteed.

For knee-specific injection choices, see PRP versus hyaluronic acid versus cortisone. For persistent tendinopathy, see our TenJet page. These options should not be presented as a mandatory ladder that every patient must climb.

What If PRP Does Not Help?

PRP can fail despite a correct diagnosis, careful preparation, accurate injection and good rehabilitation. A lack of benefit should not automatically be blamed on the patient, a low-quality product or insufficient “healing potential.”

Reassessment may identify a competing pain source, a structural problem, an inappropriate target or a need to change the rehabilitation plan. It may also show that PRP simply did not provide worthwhile benefit for this patient.

Do not keep repeating a self-pay treatment indefinitely without a measurable reason. Review function, the duration and magnitude of any benefit, the evidence for another injection and other reasonable care. See Why PRP Sometimes Does Not Work.

What Are the Risks and Limitations?

Using your own blood avoids donor-related concerns, but it does not make an injection risk-free. Risks depend on the target, technique and any additional medicines or procedures.

Blood-draw discomfort, bruising or lightheadedness.
Injection pain, temporary flare, stiffness or swelling.
Bleeding or hematoma, especially when bleeding risks are present.
Infection from a breach in sterile preparation or injection technique.
Injury to nearby nerves, blood vessels or other structures.
Reactions to an anesthetic, antiseptic or preparation additive.
Sedation-related risks when sedation is used.
Persistent symptoms, inadequate benefit or delay of more appropriate care.

Intradiscal and other deep spinal injections have additional target-specific concerns, including deep infection. Their risk discussion should not be reduced to “PRP is safe because it is natural.” Lack of proven structural healing and uncertainty about durability are also important limitations.

Does Insurance Cover PRP, and What Should the Cost Include?

Many musculoskeletal PRP treatments are not routinely covered and are offered as self-pay care. Check the current policy for the actual indication and insurer; coverage for a different use does not establish coverage for joint, tendon or spine injections.

Noncoverage should not be described simply as insurance “lagging behind the science.” Payers may cite uncertain effectiveness, inconsistent preparations or lack of sufficient evidence for the specific indication. Neither noncoverage nor a preparation device’s FDA clearance settles the clinical question.

Before agreeing to treatment, request an itemized estimate that identifies:

The target, number of injections and rationale for any proposed series.
Blood processing, clinician fees and imaging guidance.
Whether sedation is planned and billed separately.
Follow-up visits and rehabilitation costs.
What happens if you do not improve or decide not to complete a series.

Ask how the proposed benefit compares with lower-cost or covered alternatives. See our PRP insurance and cost guide.

How PRP Fits Into Care at SpinePain Solutions

Our approach starts with identifying the likely pain source and reviewing the treatments already tried. When PRP is discussed, the plan should specify the target, preparation, expected assessment interval, rehabilitation and alternatives.

PRP is an option, not an obligation. It should be reasonable to choose rehabilitation alone, another intervention, surgical consultation or continued nonsurgical care when those choices fit the diagnosis and patient goals better.

Dr. Sharma’s Treatment Perspective

The right question is not “Which regenerative product is strongest?” It is “What evidence supports this treatment for this diagnosis, and what would make it worthwhile for this patient?” A technically well-performed procedure can still fail. Good care includes acknowledging that possibility before treatment and reassessing it honestly afterward.

Questions to Ask Before a PRP Injection

What is my diagnosis, and why is this the intended target?
What do placebo-controlled studies show for this condition?
What are the reasonable alternatives, including no injection?
Which preparation will be used, and why?
Why are you recommending one injection or a series?
What activity and medication instructions apply to me?
What functional improvement would count as worthwhile?
When will we reassess, and what happens if it does not help?
What is the complete cost, including possible sedation and follow-up?

Ready to Take The Next Step?

Book an appointment with
Dr. Amit Sharma & our minimally invasive pain & spine team.

Book Online Text Us Call Us

Same-day and urgent appointments are often available.

Frequently Asked Questions About PRP Injections

What is a PRP injection?

A PRP injection uses platelet-rich plasma prepared from your own blood. The sample is processed to concentrate platelets, then injected into a selected joint or soft-tissue target. The goal is to improve symptoms and function, but benefit depends on the diagnosis and is not guaranteed.

Which tendon and joint conditions may respond to PRP?

Selected patients with knee osteoarthritis may benefit, although studies and guidelines differ. Tendon conditions require separate consideration: evidence for tennis elbow is mixed, routine use for rotator-cuff tendinopathy or partial tears is not supported by the 2025 AAOS guideline, and important Achilles and patellar trials were negative. Evidence for other joints, ligament injuries and spine targets is less established.

How long does PRP take to work?

If PRP helps, improvement is usually assessed over weeks rather than minutes. Some patients notice changes within several weeks, while others take longer or do not improve. The follow-up plan should match the treated condition and track function as well as pain.

Can pain initially get worse after PRP?

Temporary soreness, stiffness or a pain flare can occur after PRP. A flare is not proof that the treatment is working, and no flare does not mean it failed. Severe or progressively worsening pain, fever, spreading redness, drainage or new neurological symptoms require medical assessment.

How many PRP injections are usually needed?

There is no universal number. Knee studies have used one injection or a series, commonly two or three, while selected tendon protocols may start with one injection and reassessment. The diagnosis, supporting evidence, response, rehabilitation and total cost should determine the plan rather than a standard package for every patient.

Should I repeat PRP if the first injection did not help?

Not automatically. First allow the planned assessment interval, review the diagnosis and rehabilitation, and consider whether another treatment is more appropriate. Repeating PRP may be discussed after meaningful partial benefit or recurrence after a useful response, but another injection is not guaranteed to help.

Does PRP regrow cartilage or repair a torn tendon?

PRP should not be presented as a reliable way to regrow lost cartilage, reverse arthritis or reattach a completely torn tendon. Pain improvement does not prove structural regeneration. Significant tears, instability or advanced joint disease may need a different treatment plan.

Is double-spin PRP always better than single-spin PRP?

No. The number of centrifuge spins alone does not establish clinical superiority. The final platelet dose, white-cell content, red-cell contamination, processing method and evidence for the treated condition matter. A preparation method should not be advertised as universally better without appropriate clinical evidence.

Should I stop ibuprofen, aspirin or blood thinners before PRP?

Ask the treating team for individualized instructions. Some clinicians limit certain anti-inflammatory medicines around PRP, but there is no universal evidence-based hold interval for every patient. Never stop prescribed aspirin, anticoagulants or other essential medication on your own; changes may require coordination with the prescribing clinician.

Does insurance cover PRP injections?

Many musculoskeletal PRP injections are self-pay. Coverage depends on the insurer, indication and current policy, so verify benefits before treatment. Ask for an itemized estimate covering the injection, preparation, guidance, possible sedation, follow-up and any proposed series. FDA clearance of a preparation device does not guarantee coverage.

Selected References

Disclaimer: This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. PRP evidence, protocols and coverage vary by indication. Follow individualized instructions from your treating clinician and do not stop prescribed medication without medical guidance.